Publikation

Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis.

Wissenschaftlicher Artikel/Review - 18.10.2024

Bereiche
PubMed
DOI
Kontakt

Zitation
Ukegjini K, Warschkow R, Petrowsky H, Müller P, Oberholzer J, Tarantino I, Jonas J, Schmied B, Steffen T. Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis. Cancers (Basel) 2024; 16
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Cancers (Basel) 2024; 16
Veröffentlichungsdatum
18.10.2024
ISSN (Druck)
2072-6694
Kurzbeschreibung/Zielsetzung

: The aim of this study was to investigate the association between intraoperative blood transfusion (BT) and the short-term outcomes of pancreatoduodenectomy (PD) for patients with periampullary malignancies. : In a retrospective two-center cohort analysis, we utilized a logistic and mixed-effects ordinal regression, nonparametric partial correlation, and mediation analysis, complemented by propensity score matching (PSM) and weighting. : A total of 491 patients were included. Of these, 18 (3.7%) received an intraoperative BT. An intraoperative BT was associated with blood loss (odds ratio (OR) per 100 mL = 1.42; 95% CI 1.27 to 1.62; < 0.001) and relatively high ASA classes (OR = 3.75; 95% CI 1.05 to 17.74; = 0.041). Intraoperative blood loss (r = 0.27; < 0.001) but not intraoperative BT (r = 0.015; = 0.698) was associated with postoperative complications. Intraoperative BT was associated with postoperative complications according to the unadjusted regression (OR = 1.95; 95% CI 1.38-2.42, < 0.001) but not the multivariable ordinal regression. In the mediation analysis for relative risk (RR), intraoperative BT was beneficial (RR = 0.51; 95% CI: 0.01-0.78), and blood loss (RR = 2.49; 95% CI: 1.75-177.34) contributed to the occurrence of major postoperative complications. After PSM, analyses revealed that an intraoperative BT did not have a significant impact on the rates of postoperative major complications (OR = 1.048; = 0.919), clinically relevant postoperative pancreatic fistula (OR = 0.573; = 0.439) or postoperative 90-day mortality (OR = 0.714; = 0.439). : When adjusting for intraoperative blood loss, intraoperative BT is not associated with postoperative complications.